Travere Therapeutics Inc (TVTX)
EBITDA Growth
105.37%
TTM · Period ending:
TVTX EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported105.37%period ending
Latest reported105.37%period ending
TVTX TTM EBITDA YoY % (88.90% → 105.37%)
Year-over-year change
High-resolution chart · PNG
TVTX ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 105.3672% | |
| 122.9101% | |
| 108.3605% | |
| 92.3248% | |
| 67.2099% | |
| 53.2677% | |
| 17.9412% | |
| 3.094% | |
| -8.1412% | |
| -32.6205% | |
| -29.185% | |
| -27.7742% | |
| -63.6752% | |
| -72.7911% | |
| -88.6123% | |
| -16.9448% | |
| 3.2254% | |
| 12.5864% | |
| 8.4293% | |
| -270.7432% | |
| -171.5946% | |
| -113.8527% | |
| -35.3953% | |
| 35.0584% | |
| 32.1857% | |
| 9.0725% | |
| -42.8655% | |
| -0.8545% | |
| -103.1052% | |
| -111.583% | |
| -94.0576% | |
| -108.1913% | |
| 1.0945% | |
| 6.8225% | |
| 3.034% | |
| 41.9975% | |
| 1.3828% | |
| 1.7345% | |
| 25.0104% | |
| -156.0669% | |
| -38.6695% | |
| 48.0004% | |
| 50.1775% | |
| 74.8031% | |
| 59.4192% | |
| -105.9445% | |
| -336.7171% | |
| -738.3898% | |
| -1,266.3677% | |
| -2,391.0237% | |
| -58,939.9831% | |
| -130,803.8426% | |
| -53,232.5605% | |
| -13,842.6667% | |
| 658.3333% | |
| -30.2409% | |
| -15.26% | |
| -158.3602% | |
| -367.3374% | |
| -875.7143% | |
| -1,226.253% | |
| -492.3628% | |
| 119.2422% | |
| 92.9156% | |
| 88.9021% |